Tag Archive | "pharma deals"

Baxter and Merrimack ink a pharma licensing deal for developing cancer drug

Tags: , , ,


Baxter International had entered into an exclusive pharma licensing and collaboration agreement with Merrimack Pharmaceuticals to develop and commercialize lead cancer drug MM-398. Read the full story

Sobi and Biogen Idec sign a pharma deal for hemophilia

Tags: , , ,


Swedish Orphan Biovitrum has elected to add the preclinical rFVIIIFc-XTEN-vWF fusion molecule to the company's pharma deal with Biogen Idec. Read the full story

Pfizer signs a pharma deal with Novartis for two COPD drugs

Tags: , , ,


Pfizer has signed a pharma deal to promote two new drugs developed by Novartis. Read the full story

Viacyte and Janssen sign a pharma deal

Tags: , ,


ViaCyte has entered into a pharma deal with Janssen Research & Development for VC-01. Read the full story

Top 15 most partnered therapeutic trends in pharma industry

Tags: , , ,


Current Partnering releases its first update of the article previously published last year on the most partnered therapeutic trends in pharma. The article analyses the most partnered therapeutic targets of 2009-2014 and identifies the areas that have gained in popularity since last year and the new areas that have entered the list Read the full story

AstraZeneca signs pharma deal with Qiagen

Tags: , , , ,


AstraZeneca has entered into a pharma deal with  QIAGEN to develop a non-invasive diagnostic test to identify non-small cell lung cancer (NSCLC) patients who are suitable for treatment with IRESSA. Read the full story

Jazz has bought defibrotide from Sigma-Tau

Tags: , ,


Jazz Pharmaceuticals will acquire from Sigma-Tau rights to defibrotide in the United States and all other countries in the Americas. Read the full story

FSC Therapeutics signs a pharma deal with Eisai

Tags: , , ,


FSC Therapeutics has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex Sprinkle (rabeprazole sodium). Read the full story

Dimension and Bayer has signed a pharma deal

Tags: , , ,


Dimension Therapeutics announced it has entered into a pharma deal with Bayer HealthCare for the development and commercialization of a novel gene therapy for the treatment of hemophilia A. Read the full story

Big biotech, Alynylam Pharma collaboration with Alpha-1 project

Tags: ,


Alnylam Pharmaceuticals and The Alpha-1 Project have entered into a collaboration agreement for the continued advancement of ALN-AAT. Read the full story